Yuka Broderick
SVP, Investor Relations
Replay available
Datadog, Inc. (NASDAQ: DDOG) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.

SVP, Investor Relations
Co-founder & CEO
CFO
Analyst, JP Morgan
Analyst, Morgan Stanley
Analyst, Barclays
Analyst, Goldman Sachs
Analyst, William Blair
Analyst, Mizuho
Analyst, Evercore ISS
Analyst, RBC
Technical/Connection Issue
Analyst, Jefferies
Analyst, Guggenheim
Analyst (Affiliation not provided)
Analyst, TD Cowan
Good day, and thank you for standing by. Welcome to the Q1 2025 Data Dog earnings conference call. At this time, our participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Yuka Broderick from SVP of Investor Relations. Please go ahead. Thank you, Antoine. Good morning, and thank you for joining us to review Datadog's first quarter 2025 financial results, which we announced in our press release issued this morning. Joining me on the call today are Olivier Pommel, Datadog's co-founder and CEO, and David Opsler, Datadog's CFO. During this call, we will make forward looking statements, including statements related to our future financial performance, our outlook for the second quarter and the fiscal year 2025 and related notes and assumptions, our growth margins and operating margins, our product capabilities, our ability to capitalize on market opportunities and usage trends. The words anticipate, believe, continue, estimate, expect, intend, will and similar expressions are intended to identify forward looking statements or similar indications of future expectations. These statements reflect our views only as of today and are subject to a variety of risks and uncertainties that could cause actual results to defer materials. For a discussion of the material risks and other important factors that could affect our actual results, please refer to the Form 10-K where th...